Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
5.20
+2.19 (72.76%)
At close: Nov 7, 2025

RAJAF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
578578917---
Market Cap Growth
--36.97%----
Enterprise Value
578578917---
Last Close Price
5.205.208.25---
PS Ratio
463.99463.99731.35---
PB Ratio
-1080.95-1080.95-2441.10---
P/OCF Ratio
--2938.21---
EV/Sales Ratio
-464.40731.89---
EV/EBITDA Ratio
-8488.443820.26---
Debt / Equity Ratio
-0.89-0.89-1.46-4.13-0.62-8.13
Debt / EBITDA Ratio
3.013.011.661.72-65.37
Debt / FCF Ratio
---15.60--
Net Debt / Equity Ratio
-0.89-0.89-1.36-3.98-0.61-7.77
Net Debt / EBITDA Ratio
6.986.982.132.12-1.5071.78
Net Debt / FCF Ratio
-13.26-13.26-13.7115.02-1.82-4.60
Asset Turnover
0.270.270.310.320.02-
Quick Ratio
0.000.000.010.010.010.16
Current Ratio
0.190.190.120.110.200.39
Return on Assets (ROA)
-1.90%-1.90%-2.88%5.22%-9.67%-2.45%
Return on Invested Capital (ROIC)
-373.34%-373.34%-62.60%465.57%-55.31%-6.69%
Return on Capital Employed (ROCE)
26.40%26.40%50.70%59.10%99.70%-35.00%
Earnings Yield
-0.03%-0.03%-0.03%---
FCF Yield
--0.01%-0.00%---
Buyback Yield / Dilution
-6.42%---6.42%-4.42%-